Tailoring V-V Versus V-A ECMO to Recovery, Transplant and Durable Mechanical Support

Author(s): Arbour Richard

Contact Hours 2.20

CERP A 2.20

Pharmacology Hours 0.75

Expires Dec 31, 2026

Topics: Cardiovascular, Pharmacology

Population: Adult

Role: Staff, APRN

Fees
Member: Free
NonMember: $20.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Session features ECMO selection criteria as a bridge to lung versus heart transplant, recovery or mechanical circulatory support (MCS). Decision points including palliative care input, family insight and mitigating ECMO risks are analyzed. Individualized V-A/V-V ECMO titration is appraised as is reducing blood product administration to decrease alloimmunization, rejection and transfusion-related risks. Advanced case studies illustrate ECMO as bridge to recovery, transplant and MCS, ambulation during ECMO and accent the APRN role.

Objectives

  • Differentiate cardiac failure from pulmonary failure, causation and best practices for patient selection while evaluating ECMO candidacy.
  • Utilize clinical data real-time to tailor ECMO settings based on endpoints and safety through recovery, transplant or MCS evaluation.
  • Define ECMO endpoints, ethical issues and decision points along care continuum during support on recovery, transplant or MCS pathways.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.